Zur Zeit liegt uns keine Inhaltsangabe vor.
Inhaltsverzeichnis
Synthesis and Activity of Platinum Compounds. - NMR Spectroscopy of Platinum Drugs: From DNA to Body Fluids. - Trans-Diamminedichloroplatinum (II) Is Not an Antitumor Drug: Why? . - Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumor Activity. - Molecular Dynamics Simulations on Cisplatin Adducts with Dinucleotides. - Orally Active DACH-Pt (IV) Compounds. - Clinical Pharmacology. - Pharmacokinetic Pharmacodynamic Relationships. - Clinical Pharmacology of Carboplatin Administered in Alternating Sequence with Paclitaxel in Patients with Non-Small Cell Lung Cancer: A European Cancer Centre (ECC) Study. - The Clinical Development of the Oral Platinum Anticancer Agent JM216. - Biochemistry and Molecular Pharmacology. - Membrane Transport of Platinum Compounds. - Detection of Adducts Formed upon Treatment of DNA with Cisplatin and Carboplatin. - Detection of Platinum Lesions at the Nucleotide Level in Cells using Single Strand Ligation PCR. - A Review of the Modulation of Cisplatin Toxicities by Chemoprotectants. - Combination Therapy with Cisplatinum and EGF Receptor Blockade. - Clinical Studies. - Oxaliplatin: Update on a Active and Safe Dach Platinum Complex. - Combination of Different Platinum Compounds: Issues, Strategies and Experience. - Phase I and II Studies with Lobaplatin. - Phase I Trials of Ormaplatin (NSC 363812). - 254-S, NK121 and TRK710. - Clinical Trials of Oxaliplatin and DWA2114R. - Incorporating Assessments of Sequence-Dependence in Developmental Studies of Combination Chemotherapy Regimens Containing New Agents and Platinum Compounds. - Review of Carboplatin-Based High-Dose Chemotherapy Combinations in the Autotransplant Setting. - Treatment Intensification in Germ-Cell Tumours. - IL-1? Enhancement of Platinum-MediatedAnti-Tumor Activity. - Non-Platinum Metal Complexes. - Overview of Tumor-Inhibiting Non-Platinum Complexes. - How does Platinum Kill the Cell? . - The Cisplatin-Induced Cellular Injury Response. - The Interaction of Cisplatin with Signal Transduction Pathways and the Regulation of Apoptosis. - Cell Cycle Checkpoints and Cancer Chemotherapy. - Controversy Session: Cisplatin vs Carboplatin? . - Carboplatin versus Cisplatin in the Chemotherapy of Solid Tumors: Pro-Carboplatin. - Cisplatin and Carboplatin in Testis and Ovarian Cancer: Pro Cisplatin. - Resistance. - Hypersensitivity to Cisplatin in Mouse Leukemia L1210/0 Cells: An XPG DNA Repair Defect. - DNA Repair and the Carrier Ligand Specificity of Platinum Resistance. - Transcription Factor Differences in Cisplatin Resistant Cells.